Publicaciones en colaboración con investigadores/as de Humanitas University (2)

2023

  1. Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 5, pp. 1004-1016

  2. Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 10, pp. 2004-2015